Back
ProShares Ultra Bloomberg Crude Oil Vs. Summit Therapeutics, Inc. Industry Stock Comparison
Buy
59
UCO
ProShares Ultra Bloomberg Crude Oil
Last Price:
$19.83
Seasonality Move:
3.33%
Sell
37
SMMT
Summit Therapeutics, Inc.
Last Price:
$17.95
Seasonality Move:
17.44%
Buy
59
ProShares Ultra Bloomberg Crude Oil (UCO)
is a Buy
Is ProShares Ultra Bloomberg Crude Oil a Buy, Sell or Hold?
-
The current ProShares Ultra Bloomberg Crude Oil [UCO] share price is $19.71. The Score for UCO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
UCO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Summit Therapeutics, Inc. [SMMT] share price is $18.15. The Score for SMMT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UCO Stock Price Chart
What is ProShares Ultra Bloomberg Crude Oil's stock price today?
-
The ProShares Ultra Bloomberg Crude Oil share price today is $19.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UCO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics, Inc.'s stock price today?
-
The Summit Therapeutics, Inc. share price today is $18.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
UCO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.25 | Buy |
| Relative Strength Index (14 RSI): | 48.42 | Sell |
| Chaikin Money Flow: | 2248990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.18 - 20.72) | Sell |
| Bollinger Bands (100): | (20.13 - 23.19) | Sell |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.93 | Buy |
| Relative Strength Index (14 RSI): | 52.41 | Buy |
| Chaikin Money Flow: | 1537198 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.85 - 18.19) | Buy |
| Bollinger Bands (100): | (17.25 - 24.41) | Sell |
UCO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.05 | Buy |
| 20-day SMA: | 19.81 | Sell |
| 50-day SMA: | 20.41 | Sell |
| 200-day SMA: | 22.33 | Sell |
| 8-day EMA: | 12.12 | Buy |
| 20-day EMA: | 6.29 | Buy |
| 50-day EMA: | 2.82 | Buy |
| 200-day EMA: | 0.75 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.52 | Buy |
| 20-day SMA: | 17.75 | Buy |
| 50-day SMA: | 18.44 | Sell |
| 200-day SMA: | 21.9 | Sell |
| 8-day EMA: | 11.18 | Buy |
| 20-day EMA: | 5.79 | Buy |
| 50-day EMA: | 2.59 | Buy |
| 200-day EMA: | 0.69 | Buy |
ProShares Ultra Bloomberg Crude Oil Earnings Growth & UCO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics, Inc. Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and an increase next year of $0.03 per share.
ProShares Ultra Bloomberg Crude Oil Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||